billHR9058Event Friday, May 29, 2026Analyzed

To amend the Public Health Service Act to establish a grant program to promote access to automated external defibrillators and cardiopulmonary resuscitation in eligible federally assisted multifamily housing, and for other purposes.

Neutral

Summary

HR9058, an early-stage bill to establish an AED and CPR grant program for multifamily housing, has been referred to committee with no specified funding. No market impact is expected until further legislative action and appropriation details emerge.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9058 is in the earliest legislative stage with no funding authorized.
  • 2.No publicly traded companies have a direct, measurable exposure at this point.
  • 3.Market impact requires subsequent appropriations and regulatory rulemaking.

Market Implications

No immediate market implications. The bill is procedural and lacks the specificity needed to move any sector. If it advances, the likely beneficiaries would be AED manufacturers and CPR training providers, but current data provides no basis for trading decisions.

Full Analysis

On May 29, 2026, Representative Goldman (D-NY) introduced HR9058, which would amend the Public Health Service Act to create a grant program promoting access to automated external defibrillators (AEDs) and CPR training in federally assisted multifamily housing. The bill was referred to the House Committee on Energy and Commerce, marking its first step in the legislative process. As an authorization bill, HR9058 sets policy but includes no explicit funding amount—actual money would require a separate appropriations bill, which has not been introduced. With only three procedural actions (introduction and referral) and no companion bill in the Senate, the legislative path remains long and uncertain. The bill's narrow scope (multifamily housing) and early stage mean no identifiable near-term revenue impact for any public company. While AED manufacturers like Philips ($PHG) and Stryker ($SYK) could theoretically benefit if the program were funded and implemented, the lack of a dollar amount and the minimal legislative momentum make any causal chain too speculative to assess reliably. Investors should monitor committee hearings and any markup for funding specifics before adjusting positions.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderMay 29, 2026

Removing Unnecessary and Counterproductive Restrictions on Access to Federal Lands

This executive order rescinds two 1970s-era executive orders (11644 and 11989) that required federal agencies to use vague environmental and social criteria when designating off-road vehicle use on federal lands. It directs the Secretaries of War, Interior, Agriculture, the TVA Board, and other relevant agency heads to initiate rulemakings to remove or revise regulations based on those criteria, aiming to increase access for energy, timber, utility maintenance, and recreation.

Exec OrderMay 19, 2026

Restoring Integrity to America’s Financial System

This executive order directs the Treasury Department to issue an advisory to financial institutions on risks from non-work authorized populations and their employers, propose regulatory changes to strengthen Bank Secrecy Act customer due diligence and identification requirements, and consider risks from foreign consular IDs. It also directs the CFPB to clarify that deportation risk can affect ability-to-repay assessments for non-work authorized borrowers, and federal financial regulators to issue guidance on credit risks from this population.